Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective

Published:2012 Issue:4 Volume:16 Page:231
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Critical Care

Author:

Kasi Pashtoon M,Tawbi Hussein A,Oddis Chester V,Kulkarni Hrishikesh S

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Reference55 articles.

1. Economics of New Oncology Drug Development

2. Targeted cancer therapies

3. Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)

4. Off-Label Use of Rituximab in a Multipayer Insurance System

5. Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter study

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ofatumumab treatment for severe refractory anti-NMDAR encephalitis: A case series;Journal of Neuroimmunology;2024-11

2. The Therapeutic Mechanisms of Honey in Mitigating Toxicity from Anticancer Chemotherapy Toxicity: A Review;Journal of Xenobiotics;2024-08-20

3. Effects of home-based exercise with telehealth guidance in lymphoma cancer survivors entering cardio-oncology rehabilitation: rationale and design of the tele@home study;Cardio-Oncology;2024-07-30

4. Sleep Disorders in Connective Tissue Diseases—Coexisting Diseases or Disease Components?;Journal of Clinical Medicine;2024-06-22

5. Treatment of calcinosis cutis associated with autoimmune connective tissue diseases;Archives of Dermatological Research;2024-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3